Tolnaftate

Tolnaftate 1%

Antifungal

• proven clinically effective in the treatment of athlete's foot (tinea pedis) and ringworm (tinea corporis)
• prevents the recurrence of most athlete's foot with daily use
• for effective relief of itching, cracking and burning

For external use only.

​Flammable:

Contents under pressure. Avoid spraying in eyes. Do not use or store near heat or flame. Do not puncture or incinerate container. Do not store at temperature above 120ºF. Keep out of the reach of children. Use only as directed. Intentional misuse by delibrately concentrating and inhaling the contents can be harmful or fatal.

When using this product

• avoid contact with the eyes or mouth
• use only as directed

Stop use and ask a doctor if

• irritation occurs
• no improvement within 4 weeks for athlete's foot and ringworm

Do not use

on children under 2 years of age unless directed by a doctor.

Keep out of the reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

• wash affected area and dry thoroughly
• shake can well and spray a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor
• supervise children in the use of this product
• for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least once daily
• for athlete's foot and ringworm, use daily for 4 weeks
• if condition persists, consult a doctor
• to prevent athlete's foot: wash the feet and dry thoroughly; spray a thin layer of the product to the feet once or twice daily (morning and/or night)
• this product is not effective on the scalp or nails
• if nozzle clogs, clean with a pin

store between 20º and 30ºC (68º and 86ºF)

BHT, isobutane, PPG-12-buteth-16, SD alcohol 40-B

Call 1-866-964-0939

Antifungal

Liquid Spray

tolnaftate 1%

Cures most athlete's foot & prevents recurrences

Relieves itching, cracking & burning

NET WT 5.3 OZ (150g)

[Image in the official label — see DailyMed source]